Locations of interest | |
Credentials | None |
1999 Stanford University , BS , Computer Science |
Investing across all sectors and stages, with a particular passion for companies reinventing huge industries like healthcare, biotechnology and education. Brian sits on the boards of AltSchool, Emerald Therapeutics, and Oscar. He was also a board director at Stemcentrx before the company was acquired by AbbVie in 2016 in the largest private biotech acquisition to date.